Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). NKGen Biotech's share price for the quarter that ended in Mar. 2025 was $0.18. NKGen Biotech's Shares Outstanding (EOP) for the quarter that ended in Mar. 2025 was 51.31 Mil. Therefore, NKGen Biotech's market cap for the quarter that ended in Mar. 2025 was $9.24 Mil.
NKGen Biotech's quarterly market cap
increased
from Sep. 2024 ($13.50 Mil) to Dec. 2024 ($28.99 Mil) but then
declined
from Dec. 2024 ($28.99 Mil) to Mar. 2025 ($9.24 Mil).
NKGen Biotech's annual market cap
increased
from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($60.19 Mil) but then
declined
from Dec. 2023 ($60.19 Mil) to Dec. 2024 ($28.99 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. NKGen Biotech's Enterprise Value for Today is $46.02 Mil.
NKGen Biotech (OTCPK:NKGN) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
NKGen Biotech Market Cap Related Terms
NKGen Biotech Market Cap Historical Data
* Premium members only.
The historical data trend for NKGen Biotech's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, NKGen Biotech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NKGen Biotech Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, NKGen Biotech's Market Cap distribution charts can be found below:
* The bar in red indicates where NKGen Biotech's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
NKGen Biotech's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NKGen Biotech (NKGN) has a Market Cap of $7.84 Mil as of Jul. 14, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on NKGen Biotech and its competitors.
Is NKGen Biotech's Market Cap too high?
NKGen Biotech's current Market Cap is $7.84 Mil. The Biotechnology industry median Market Cap is 115.88. NKGen Biotech's value of $7.84 Mil is 93.2% below this industry median.
How does NKGen Biotech's Market Cap compare to CALC and CLGN?
NKGen Biotech's Market Cap of $7.84 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 115.88. NKGen Biotech's value of $7.84 Mil is 93.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 115.88, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NKGen Biotech's current Market Cap of $7.84 Mil is 93.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on NKGen Biotech and its competitors. For the Biotechnology industry, the median Market Cap is 115.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NKGen Biotech's current Market Cap is $7.84 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NKGen Biotech stock overvalued right now?
NKGen Biotech (NKGN) has a current Market Cap of $7.84 Mil. The current Market Cap is $7.84 Mil and 93.2% below the Biotechnology industry median of 115.88. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For NKGen Biotech (NKGN), the current Market Cap is $7.84 Mil as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NKGN has been successfully added to your 
